Tirzepatide and alcohol: what to know before you drink
Zepbound™ and Mounjaro® don't list alcohol as a contraindication, but it can worsen nausea, dehydration, and blood sugar swings during…
Read more →
Category
Weight Management
Evidence-based guidance on GLP-1 and GLP-1/GIP medicines, appetite and metabolism, and what sustainable, medically supervised weight care actually involves.
Board-Certified Clinicians
503A Licensed Pharmacies
HIPAA Compliant
Articles
In Weight Management
Ozempic® vs Wegovy®: same ingredient, different approvals and doses
Ozempic® and Wegovy® both contain semaglutide, but they have separate FDA approvals, labels, and maximum doses. Here's how they…
Read more →
GLP-1 pills explained: how oral options differ from weekly injections
The FDA approved an oral semaglutide tablet for weight management. Here's how GLP-1 pills compare to weekly injections, and how compounded oral…
Read more →
Wegovy® side effects: a plain-language guide to what the label says
Wegovy® side effects range from common GI symptoms to rare but serious warnings. Here's what the label says, and why gradual dosing…
Read more →
Tirzepatide side effects: what is common, what is rare, and when to call a clinician
Tirzepatide side effects range from common GI symptoms to rare but serious warnings. Here's what the label says, and when to call…
Read more →
How tirzepatide dosing works: the gradual step-up schedule explained
Tirzepatide dosing starts low and rises gradually. Here's the labeled step-up schedule for Zepbound™, from starting dose to maintenance…
Read more →
GLP-1 medications and mood: what the FDA's 2026 safety update means
In January 2026 the FDA asked for suicidal-thoughts warnings to be removed from GLP-1 labels. Here's what the review found, and what to still…
Read more →
GLP-1 weight-loss plateau: why it happens and what to do next
Weight loss on GLP-1 medications often slows after the first few months. Here's why plateaus happen, and when it's worth talking to your…
Read more →
GLP-1 medications and drug interactions: what to tell your doctor
GLP-1 medications can change how your body absorbs other drugs, including birth control and insulin. Here's what FDA labeling says to…
Read more →
GLP-1 medications and bone health: what to know
A 2026 study found GLP-1 users without diabetes lost more hip bone density than matched non-users. Here's what the research shows, and doesn't…
Read more →
GLP-1 medications and 'food noise': what patients report
Some patients say GLP-1 medications quiet persistent thoughts about food. Here's what "food noise" means, what's known, and why responses…
Read more →
Semaglutide vs. tirzepatide: how do they compare?
Semaglutide and tirzepatide are both used for weight management, but they work differently. Here's how their mechanisms, dosing, and side effects…
Read more →
GLP-1 medications and skin changes during weight loss
Significant weight loss can change facial and skin volume, sometimes called "Ozempic face." Here's what's actually happening, and what may…
Read more →
GLP-1 medications and heart health: what to know
In March 2024, the FDA approved semaglutide (Wegovy) to reduce cardiovascular risk in adults with heart disease and obesity. Here's what that…
Read more →
GLP-1 medications and kidney health: what to know
Acute kidney injury linked to dehydration has been reported with GLP-1 medications. Here's what FDA labeling says, and what newer research also…
Read more →
GLP-1 medications and gallbladder health: what to know
Gallstones and gallbladder problems have been reported with semaglutide and tirzepatide. Here's why weight loss raises the risk, and when to call your…
Read more →
GLP-1 medications and pregnancy planning: what to know before you conceive
FDA labeling recommends discontinuing semaglutide or tirzepatide at least two months before a planned pregnancy. Here's what to know about timing,…
Read more →
GLP-1 medications and sleep apnea: what the new FDA approval means
In December 2024, the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity. Here's what that approval means and…
Read more →
Hair loss and GLP-1 medications: what to know
Hair loss has been reported in clinical trials of semaglutide and tirzepatide, but it's often linked to rapid weight loss itself, a temporary condition…
Read more →
Semaglutide and alcohol: what to know before you drink
Semaglutide slows digestion and can affect blood sugar, both of which change how alcohol affects you. Here's what to know before you drink during…
Read more →
GLP-1 medications and surgery: why your care team may ask you to pause treatment
GLP-1 medications slow digestion, which is why anesthesia teams ask about them before a procedure. Here's what patients should know about timing and…
Read more →
Preserving muscle mass during GLP-1 treatment
GLP-1 weight loss can include some loss of lean muscle, not just fat. Here's what the research shows, and how protein intake and strength training may…
Read more →
Who's eligible for medical weight management?
Eligibility for medical weight management is determined individually by a licensed clinician, not by a fixed chart. An online evaluation reviews your…
Read more →
Sublingual and troche formulations of GLP-1s
Sublingual and troche GLP-1 forms are compounded preparations designed to dissolve in the mouth. Compounded medications are not FDA-approved and have…
Read more →
Side effects of GLP-1 medications
The most common GLP-1 side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal pain, often mild and easing over…
Read more →
Oral vs injectable GLP-1 options
GLP-1 medications come in injectable and other formulations, including oral and compounded preparations. Which is suitable is a clinical decision…
Read more →
Microdosing GLP-1s explained
Microdosing GLP-1s is an informal term for using doses below standard prescribing levels. GLP-1 dosing is individualised and directed by a licensed…
Read more →
Maintaining weight after GLP-1 treatment
Maintaining weight after a course of GLP-1 treatment is supported by ongoing nutrition and physical activity, along with a clinician's help planning…
Read more →
How compounded GLP-1s work
GLP-1 medications activate the GLP-1 receptor, the same appetite- and digestion-regulating pathway your body uses naturally. They slow stomach…
Read more →
What to expect in your first month of GLP-1 treatment
In the first month of GLP-1 treatment, dosing is typically started low and increased gradually under a licensed clinician's direction. Early side…
Read more →
Compounded tirzepatide vs Zepbound™: what's the same, what's different
Zepbound (tirzepatide) is FDA-approved for chronic weight management with FDA-reviewed labeling. Compounded tirzepatide shares the same active…
Read more →
What is compounded semaglutide?
What semaglutide is, what “compounded” means, and how it’s prescribed.
Read more →
What is compounded tirzepatide?
What tirzepatide is, the GLP-1/GIP mechanism, and what “compounded” means.
Read more →
Compounded semaglutide vs Wegovy®: the key differences
Wegovy (semaglutide) is FDA-approved for chronic weight management with FDA-reviewed labeling. Compounded semaglutide shares the same active molecule…
Read more →
Common questions
Weight Management FAQs
What is compounded semaglutide?
Semaglutide is a GLP-1 medication. A compounded version is prepared by a licensed compounding pharmacy for an individual patient when clinically appropriate. Compounded medications, including semaglutide, are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality, but may be prescribed by independent licensed physicians in certain circumstances, such as during FDA-declared shortages or to meet specific patient needs.
How is compounded tirzepatide different from Wegovy® or Zepbound™?
Wegovy® (semaglutide) and Zepbound™ (tirzepatide) are FDA-approved brand-name products. A compounded formulation is prepared by a licensed pharmacy for an individual patient and is not FDA-approved. Whether any option is appropriate for you is a clinical decision made by an independent licensed medical professional after an online evaluation.
Am I eligible for a Lovely Meds weight consultation?
Eligibility is determined individually. When you complete an online evaluation, an independent licensed medical professional reviews your health history and goals and determines whether treatment is appropriate for you. The consultation itself does not guarantee that any specific treatment will be prescribed.
How does the online consultation work?
You complete a confidential online evaluation about your health. An independent licensed clinician reviews it and, if appropriate, discusses options with you. If treatment is prescribed, it is dispensed through a licensed U.S. pharmacy. Education on this page is not a substitute for that evaluation.
What side effects should I be aware of?
GLP-1 medications commonly cause gastrointestinal side effects such as nausea, diarrhea, constipation, and abdominal discomfort, which are often mild and tend to ease over time. Serious side effects are possible. Any article discussing a specific medication includes full Important Safety Information, and you should discuss risks with your clinician.
Talk to a Lovely Meds clinician about medical weight management
An independent, licensed medical professional will review your online evaluation and determine whether treatment is appropriate for you.
Start a free consultation →